Man Group
ANGO icon

Man Group’s AngioDynamics ANGO Stock Holding History

Man Group’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-25,971
Closed -$271K – 1657
2020
Q1 		$271K Sell
25,971
-8,307
-24% -$104K ﹤0.01% 1406
2019
Q4 		$549K Buy
34,278
+9,432
+38% +$144K ﹤0.01% 1580
2019
Q3 		$458K Sell
24,846
-32,247
-56% -$631K ﹤0.01% 1593
2019
Q2 		$1.12M Sell
57,093
-216,706
-79% -$4.41M ﹤0.01% 1490
2019
Q1 		$6.26M Sell
273,799
-9,848
-3% -$214K 0.02% 792
2018
Q4 		$5.71M Sell
283,647
-231,317
-45% -$4.79M 0.03% 713
2018
Q3 		$11.2M Sell
514,964
-46,346
-8% -$1.03M 0.04% 565
2018
Q2 		$12.5M Sell
561,310
-108,463
-16% -$2.22M 0.05% 466
2018
Q1 		$11.6M Buy
+669,773
New +$11.2M 0.05% 417

Other funds holding ANGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return

Man Group's ANGO Position: Q2 2020 in Review

Man Group sold out of AngioDynamics (ANGO) in Q2 2020, closing a stake of 25,971 shares — an estimated $271K sold.

Man Group first reported a position in ANGO in Q1 2018 and held it in 9 quarters. The position peaked at $12.5M in Q2 2018. 146 funds tracked by Wall St. Rank hold ANGO as of Q2 2020.

  • Man Group reported no remaining AngioDynamics position as of Q2 2020 after selling out during the quarter.
  • Man Group sold 25,971 AngioDynamics shares in Q2 2020, an estimated $271K.
  • Man Group first reported a position in AngioDynamics in Q1 2018 and held it in 9 quarters.
  • Man Group's AngioDynamics position peaked at $12.5M in Q2 2018.
  • 146 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2020.

Based on Man Group's 13F filing for Q2 2020, filed 14 Aug 2020.